Guideline for optimization of colorectal cancer surgery and pathology

Journal of Surgical Oncology

Volumn 101, Issue 1, 2010, Pages 5-12

  Smith, Andrew J ^a   Driman, David K ^b   Spithoff, Karen ^c   Hunter, Amber ^d   Mcleod, Robin S ^d,e   Simunovic, Marko ^f   Langer, Bernard ^d  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d CANCER CARE ONTARIO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Lymphadenectomy; Practice guideline; Resection margins

Indexed keywords

ACCURACY; CANADA; CANCER SURGERY; COLORECTAL CANCER; DECISION MAKING; HUMAN; LYMPH NODE; LYMPHADENECTOMY; MEDLINE; PATHOLOGIST; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RECTUM RESECTION; REVIEW; SURGEON; SYSTEMATIC REVIEW; TUMOR PERFORATION;

COLORECTAL NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; PRACTICE GUIDELINES AS TOPIC; RECTUM;

EID: 74049108884     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21395     Document Type: Review

References (47)

1. National Cancer Institute of Canada (NCIC): Canadian cancer statistics 2007. Toronto, ON: National Cancer Institute of Canada; 2007.
2. Greene FL, Page DL, Fleming ID, et al.: editors. AJCC cancer staging manual. 6th edition. New York, NY: Springer; 2002.
3. Wright FC, De Vito C, Langer B, et al.: Multidisciplinary cancer conferences: A systematic review and development of practice standards. Eur J Cancer 2007;43:1002-1010.
4. MERCURY study group: Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study. Br Med J 2006; 333:779.
5. Govindarajan A, Fraser N, Cranford V, et al.: Predictors of multivisceral resection in patients with locally advanced colorectal cancer. Ann Surg Oncol 2008;15:1923-1930.
6. Lemmens VE, van Lijnschoten I, Janssen-Heijnen ML, et al.: Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: A population-based study. Ann Oncol 2006;17:1803-1809.
7. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al.: Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 2007;99:433-441.
8. Wright FC, Law CHL, Berry S, et al.: Clinically important aspects of lymph node assessment in colon cancer. J Surg Oncol 2009; 99:248-255.
9. Bilimoria KY, Bentrem DJ, Stewart AK, et al.: Lymph node evaluation as a colon cancer quality measure: A national hospital report card. J Natl Cancer Inst 2008;100:1310-1317.
10. Smith AJ, Driman DK, Spithoff K, et al.: Optimization of surgical and pathological quality performance in radical surgery for colon and rectal cancer: Margins and lymph nodes; 2008 [cited 2009 August 10]. Available at: www.cancercare.on.ca/pdf/pebc17-4f.pdf.
11. Browman GP, Levine MN, Mohide EA, et al.: The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995; 13:502-512.
12. Nelson H, Petrelli N, Carlin A, et al.: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583-596.
13. The AGREE Collaboration: Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument; 2001 [cited 2009 August 10]. Available at: www.agreetrust.org.
14. Quirke P, Morris E: Reporting colorectal cancer. Histopathology 2007;50:103-112.
15. Burroughs SH, Williams GT: Examination of large intestine resection specimens. J Clin Pathol 2000;53:344-349.
16. Ludeman L, Shepherd NA: Macroscopic assessment and dissection of colorectal cancer resection specimens. Curr Diagn Pathol 2006;12:220-230.
17. Compton CC: Colon and rectum: Protocol [monograph on the Internet]. Northfield (IL): College of American Pathologists; 2005 [cited 2009 August 10]. Available from: http://www.cap.org/apps/ docs/cancer-protocols/2005/ colonrectum05-pw.pdf.
18. Jatzko GR, Jagoditsch M, Lisborg PH, et al.: Long-term results of radical surgery for rectal cancer: Multivariate analysis of prognostic factors influencing survival and local recurrence. Eur J Surg Oncol 1999;25:284-291
19. Bokey EL, Ojerskog B, Chapuis PH, et al.: Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: Role of total anatomical dissection. Br J Surg 1999;86: 1164-1170.
20. Bufalari A, Boselli C, Giustozzi G, et al.: Locally advanced rectal cancer: A multivariate analysis of outcome risk factors. J Surg Oncol 2000;74:2-10.
21. Stocchi L, Nelson H, Sargent DJ, et al.: Impact of surgical and pathologic variables in rectal cancer: A United States Community and Cooperative Group report. J Clin Oncol 2001;19:3895-3902.
22. Law WL, Chu KW: Anterior resection for rectal cancer with mesorectal excision: A prospective evaluation of 622 patients. Ann Surg 240:260-268.
23. Laurent C, Nobili S, Rullier A, et al.: Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg 2006;203:684-691.
24. Chiappa A, Biffi R, Bertani E, et al.: Surgical outcomes after total mesorectal excision for rectal cancer. J Surg Oncol 2006;94:182-193.
25. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, et al.: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: Not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-357.
26. Wibe A, Rendedal PR, Svensson E, et al.: Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-334.
27. Birbeck KF, Macklin CP, Tiffin NJ, et al.: Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-457.
28. Marijnen CAM, Nagtegaal ID, Kapiteijn E, et al.: Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1311-1320.
29. Simunovic M, Stewart L, Zwaal C, et al.: Diagnostic Imaging Guidelines Panel, Cross-sectional imaging in colorectal cancer. 2006 April 12 [cited 2009 August 10]. Available from: http:// www.cancercare.on.ca/pdf/pebcdicrc.pdf.
30. Di Matteo G, Maturo A, Redler A, et al.: Local recurrences and primary surgery in rectal carcinoma. Panminerva Med 2000;42: 201-205.
31. Shirouzu K, Ogata Y, Araki Y, et al.: Total mesorectal excision, lateral lymphadenectomy and autonomic nerve preservation for lower rectal cancer: Significance in the long-term follow-up study. Karume Med J 2001;48:307-319.
32. Nesbakken A, Nygaard K, Westerheim O, et al.: Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002;28:126-134.
33. Wibe A, Moller B, Norstein J, et al.: A national strategic change in treatment policy for rectal cancer-Implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857-866.
34. Kapiteijn E, Putter H, van de Velde CJH: Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002;89:1142-1149.
35. Bulow S, Christensen IJ, Harling H, et al.: Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 2003;90:974-980.
36. Bernardshaw SV, Ovrebo K, Eide GE, et al.: Treatment of rectal cancer: Reduction of local recurrence after the introduction of TME - Experience from one university hospital. Dig Surg 2006; 23:51-59.
37. Govindarajan A, Coburn NG, Kiss A, et al.: Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006;98:1474-1481.
38. Wibe A, Syse A, Andersen E, et al.: Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: Anterior vs. abdominoperineal resection. Dis Colon Rectum 2004;47:48-58.
39. Eriksen MT,Wibe A, Syse A, et al.: Inadvertent perforation during rectal cancer resection in Norway. Br J Surg 2004;91:210-216.
40. Quirke P, Dixon MF: The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3:127-131.
41. Parfitt JR, Driman DK: The total mesorectal excision specimen for rectal cancer: A review of its pathological assessment. J Clin Pathol 2007;60:849-855.
42. Shepherd NA, Baxter KJ, Love SB: The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluation. Gastroenterology 1997;112:1096-1102.
43. Ludeman L, Shepherd NA: Serosal involvement in gastrointestinal cancer: Its assessment and significance. Histopathology 2005;47: 123-131.
44. Fleshman JW, Wexner SD, Anvari M, et al.: Laparoscopic vs. open abdominoperineal resection for cancer. Dis Colon Rectum 1999;42:930-939.
45. Kawamura YJ, Umetani N, Sunami E, et al.: Effect of high ligation on the long-term result of patients with operable colon cancer, particularly those with limited nodal involvement. Eur J Surg 2000;166:803-807.
46. Bui L, Rempel E, Reeson D, et al.: Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol 2006:439-445.
47. Davis D, Evans M, Jadad A, et al.: The case for knowledge translation: Shortening the journey from evidence to effect. Br Med J 2003;327:33-35.